XBIO — Xenetic Biosciences Balance Sheet
0.000.00%
Last trade - 00:00- $7.01m
- -$0.87m
- $2.98m
Annual balance sheet for Xenetic Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 18.2 | 13.1 | 8.98 | 6.17 | 7.88 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18.7 | 13.7 | 9.59 | 6.59 | 8.05 |
| Net Property, Plant And Equipment | 0 | — | — | — | — |
| Other Long Term Assets | |||||
| Total Assets | 19.8 | 14.7 | 10.6 | 6.9 | 8.36 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 1.42 | 1.07 | 0.81 | 0.894 | 0.968 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.42 | 1.07 | 0.81 | 0.894 | 0.968 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 18.4 | 13.6 | 9.8 | 6.01 | 7.4 |
| Total Liabilities & Shareholders' Equity | 19.8 | 14.7 | 10.6 | 6.9 | 8.36 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |